A Relative Bioavailability Study of 60 mg Nifedipine Extended Release Tablets Under Fasting Conditions

NCT00865891 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

96

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Nifedipine Extended Release tablets 60 mg, single dose
DRUG: ADALAT® CC Extended Release Tablets 60 mg

Sponsor

Actavis Inc.